Report cover image

Glaucoma Eye Drops Market, by Drug Type (Prostaglandin analogs, Beta blockers, Alpha agonists, Carbonic Anhydrase Inhibitors (CAIs), Combined Medications and Others (rho-kinase inhibitor, Cholinergic agonist), by Disease Indication (Angle-closure Glaucoma

Publisher Coherent Market Insights
Published Mar 25, 2025
Length 144 Pages
SKU # CMI20007816

Description

Glaucoma is a group of eye diseases that can cause vision loss and blindness by damaging a nerve in the back of your eye called the optic nerve. The symptoms can start so slowly that a patient may not notice them. The only way to find out if a person has glaucoma is to get a comprehensive dilated eye exam. Glaucoma may occur among people with or without diabetes. Moreover, people with diabetic retinopathy have an increased risk of glaucoma. The condition is associated with abnormal blood vessel growth, which can result in retinopathy and leads to blockage of natural drainage of the eye. Rapidly increasing geriatric population is one of the important factors for the increasing prevalence of glaucoma, which in turn is projected to drive the growth of the glaucoma therapeutics market in the near future.

Market Dynamics

The global glaucoma eye drops market is expected to witness significant growth during the forecast period owing to the increasing prevalence of glaucoma. For instance, according to the Centre for Disease Control and Prevention, in November 2020, an estimated 3 Mn people suffered from blindness due to glaucoma in the U.S. 2020.

Key features of the study:
  • This report provides in-depth analysis of the global glaucoma eye drops market, market size (US$ Mn), and compound annual growth rate (CAGR (%) for the forecast period: 2025-2032, considering 2024 as the base year
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by leading players
  • It profiles key players in the global glaucoma eye drops market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
  • Key players covered as a part of this study include Merck KGaA, Allergan plc ( A subsidiary of AbbVie Inc.), Novartis AG, Teva Pharmaceutical Industries Ltd., Pfizer, Inc., Bausch & Lomb, Inotek, Jadran-galenski laboratorij d.d. JGL d.d, Aerie Pharmaceutical (A subsidiary of Alcon Management S. A) and Mylan N.V (A subsidiary of Viatris Inc.)
  • Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launches, government initiatives, technological upgradation, market expansion, and marketing tactics.
  • The global glaucoma eye drops market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors, and suppliers for glaucoma eye drops, research and consulting firms, new entrants, and financial analysts.
Detailed Segmentation:
  • Global Glaucoma Eye Drops Market, By Drug Type:
  • Prostaglandin analogs
  • Beta blockers
  • Alpha agonists
  • Carbonic Anhydrase Inhibitors (CAIs)
  • Combined Medications
  • Others (rho-kinase inhibitor, Cholinergic agonist)
  • Global Glaucoma Eye Drops Market, By Disease Indication:
  • Angle-closure Glaucoma
  • Open-angle Glaucoma
  • Global Glaucoma Eye Drops Market, By Distribution Channel:
  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy
  • Global Glaucoma Eye Drops Market, By Composition:
  • Preservative Free
  • BAK-Based
  • Non BAK-Based Preservatives
  • Global Glaucoma Eye Drops Market, By Region:
  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East
  • Africa
  • Company Profiles
  • Merck KGaA
  • Allergan plc ( A subsidiary of AbbVie Inc)
  • Novartis AG
  • Teva Pharmaceutical Industries Ltd.
  • Pfizer, Inc.
  • Bausch & Lomb
  • Inotek
  • Jadran-galenski laboratorij d.d. JGL d.d
  • Aerie Pharmaceutical (A subsidiary of Alcon Management S. A)
  • Mylan N.V. (A subsidiary of Viatris Inc.)

Table of Contents

144 Pages
1. Research Objectives and Assumptions
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Market Snapshot, By Drug Type
Market Snapshot, By Disease Indication
Market Snapshot, By Distribution Channel
Market Snapshot, By Composition
Market Snapshot, By Region
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Drivers
Restraints
Market Opportunities
Impact Analysis
Recent Product Launches
Epidemiology
Merger, Acquisition, and Collaboration
Regulatory Scenario
Key Developments
PEST Analysis
4. Global Glaucoma Eye Drops Market– COVID-19 Impact Analysis
Economic Impact
COVID-19 Epidemiology
Impact on Supply and Demand
5. Global Glaucoma Eye Drops Market, By Drug Type, 2020–2032, (US$ Million)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021–2032
Segment Trends
Prostaglandin analogs
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020 – 2032, (US$ Mn)
Beta blockers
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020 – 2032, (US$ Mn)
Alpha agonists
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020 – 2032, (US$ Mn)
Carbonic Anhydrase Inhibitors (CAIs)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020 – 2032, (US$ Mn)
Combined Medications
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020 – 2032, (US$ Mn)
Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020 – 2032, (US$ Mn)
6. Global Glaucoma Eye Drops Market, By Disease Indication, 2020–2032, (US$ Million)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021–2032
Segment Trends
Angle-closure Glaucoma
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020 – 2032, (US$ Mn)
Open-angle Glaucoma
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020 – 2032, (US$ Mn)
7. Global Glaucoma Eye Drops Market, By Distribution Channel, 2020–2032, (US$ Million)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021–2032
Segment Trends
Hospital Pharmacy
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020 – 2032, (US$ Mn)
Retail Pharmacy
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020 – 2032, (US$ Mn)
Online Pharmacy
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020 – 2032, (US$ Mn)
8. Global Glaucoma Eye Drops Market, By Composition, 2020–2032, (US$ Million)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021–2032
Segment Trends
Preservative Free
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020 – 2032, (US$ Mn)
BAK-Based
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020 – 2032, (US$ Mn)
Non BAK-Based Preservatives
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020 – 2032, (US$ Mn)
9. Global Glaucoma Eye Drops Market, By Region, 2020–2032, (US$ Million)
Introduction
Market Share Analysis, By Region, 2025 and 2032 (%)
Y-o-Y Growth Analysis, For Regions, 2021–2032
Regional Trends
North America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2020 - 2032, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2020 - 2032, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Composition, 2020 - 2032, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 – 2032, (US$ Million)
U.S.
Canada
Latin America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Drug type, 2020 - 2032, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2020 - 2032, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Composition, 2020 - 2032, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2020– 2032, (US$ Million)
Brazil
Mexico
Argentina
Rest of Latin America
Europe
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Drug type, 2020 - 2032, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2020 - 2032, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Composition, 2020 - 2032, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2020– 2032, (US$ Million)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Drug type, 2020 - 2032, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2020 - 2032, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Composition, 2020 - 2032, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2020– 2032, (US$ Million)
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Middle East
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Drug type, 2020 - 2032, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2020 - 2032, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Composition, 2020 - 2032, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2020– 2032, (US$ Million)
GCC
Israel
Rest of Middle East
Africa
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Drug type, 2020 - 2032, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2020 - 2032, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Composition, 2020 - 2032, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2020– 2032, (US$ Million)
North Africa
Central Africa
South Africa
10. Competitive Landscape
Merck KGaA
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Allergan plc ( A subsidiary of AbbVie Inc)
Novartis AG
Teva Pharmaceutical Industries Ltd.
Pfizer, Inc.
Bausch & Lomb
Inotek
Jadran-galenski laboratorij d.d. JGL d.d
Aerie Pharmaceutical (A subsidiary of Alcon Management S. A)
Mylan N.V. (A subsidiary of Viatris Inc.)
11. Section
Research Methodology
About Us
*Browse 43 market data tables and 37 figures on “Glaucoma Eye Drops Market” - forecast to 2032

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us